Lumigan 0.01% Ophthalmic Solution
Prescription Required
Product introduction
Lumigan 0.01% Ophthalmic Solution is a medicine used to reduce pressure in the eyes in adults with glaucoma and high pressure in the eye. If the pressure in your eye is too high it can damage your sight, potentially leading to blindness. It works by helping fluid flow from inside the eye into the blood.
Lumigan 0.01% Ophthalmic Solution is to treat increased pressure inside the eye
Lumigan 0.01% Ophthalmic Solution is to treat increased pressure inside the eye
Uses of Lumigan Ophthalmic Solution
- Ocular hypertension
- Glaucoma
Benefits of Lumigan Ophthalmic Solution
In Ocular hypertension
Lumigan 0.01% Ophthalmic Solution belongs to a group of medicines called prostaglandin analogue. It is used to reduce pressure in your eyes. It increases the flow of fluid from inside the eye into the bloodstream thereby lowering the increased eye pressure. If the pressure in your eye is too high, it can damage your sight. Take it regularly as prescribed by your doctor. If you stop taking it, the pressure in your eye will not be controlled.
In Glaucoma
Lumigan 0.01% Ophthalmic Solution helps reduce pressure in your eyes (ocular hypertension) that can lead to an illness called glaucoma. It may be used alone or with other eye drops. Do not use it too often as that can make it less effective. You should only use it in the affected eye and take it regularly as prescribed by your doctor. If you stop taking it, the pressure in your eye will not be controlled. This could lead to a loss of sight.
Side effects of Lumigan Ophthalmic Solution
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Lumigan
- Conjunctival hyperemia
- Eye itching
How to use Lumigan Ophthalmic Solution
This medicine is for external use only. Take it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off extra liquid.
Safety advice
Alcohol
No interaction found/established
Pregnancy
SAFE IF PRESCRIBED
Lumigan 0.01% Ophthalmic Solution is safe to use during pregnancy. Most studies have shown low or no risk to the developing baby.
Breast feeding
SAFE IF PRESCRIBED
Lumigan 0.01% Ophthalmic Solution is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
To reduce the amount of Lumigan 0.01% Ophthalmic Solution that reaches the breastmilk, place pressure over the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.
To reduce the amount of Lumigan 0.01% Ophthalmic Solution that reaches the breastmilk, place pressure over the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.
Driving
UNSAFE
Lumigan 0.01% Ophthalmic Solution may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Kidney
No interaction found/established
Liver
No interaction found/established
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Lumigan 0.01% Ophthalmic Solution
₹656.52/Ophthalmic Solution
Lowprost Eye Drop
Cipla Ltd
₹266.2/ophthalmic solution
59% cheaper
Bimaday Eye Drop
Micro Labs Ltd
₹350/ophthalmic solution
47% cheaper
Bimato MS Eye Drops
Guerison MS Inc.
₹395/ophthalmic solution
40% cheaper
Synoprost LS Eye Drop
Synovia Life Sciences Pvt Ltd
₹149/ophthalmic solution
77% cheaper
Quick tips
- Lumigan 0.01% Ophthalmic Solution helps lower high pressure in the eye and reduces the risk of vision loss.
- For best results, put one drop once a day in the evening/night in the affected eye(s).
- Lumigan 0.01% Ophthalmic Solution may cause brown pigmentation of the iris. This discoloration may be permanent.
- Your eyelashes may become more dense and eyelid skin may darken. These changes should disappear after discontinuing Lumigan 0.01% Ophthalmic Solution.
- Wait for at least 5-10 minutes before delivering the next medication in the same eye to avoid dilution.
- Apply pressure on the corner of the eye (close to the nose) for about 1 minute, immediately after instilling the drop.
Fact Box
Chemical Class
Prostaglandin analogue
Habit Forming
No
Therapeutic Class
OPHTHAL
Action Class
PG F2 Alpha analogue
Patient concerns
User feedback
Patients taking Lumigan 0.01% Ophthalmic Solution
Once A Day
92%
Twice A Day
6%
Thrice A Day
1%
What are you using Lumigan Ophthalmic Solution for?
Glaucoma
95%
Others
5%
How much was the improvement?
Excellent
61%
Average
35%
Poor
4%
What were the side-effects while using Lumigan 0.01% Ophthalmic Solution?
No Side Effec*
67%
Eye itching
33%
*No Side Effect
How do you take Lumigan Ophthalmic Solution?
With or witho*
80%
With food
20%
*With or without food
Please rate Lumigan 0.01% Ophthalmic Solution on price
Expensive
88%
Average
12%
FAQs
What happens if I stop using Lumigan 0.01% Ophthalmic Solution?
If you stop using Lumigan 0.01% Ophthalmic Solution, the eyelashes may return to their previous appearance after several weeks or months. In case you have developed any eyelid skin darkening, it may reverse after several weeks or months. However, any change in the color of the iris is permanent and will not reverse.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 144-45.
- Smyth EM, FitzGerald GA. The Eicosanoids: Prostaglandins, Tromboxanes, Leukotriens, & Related Compounds. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 328.
- ScienceDirect. Bimatoprost. [Accessed 04 Apr. 2019] (online) Available from:
- Bimatoprost ophthalmic solution. Irvine, California: Allergan, Inc.; 2001 [revised Sep. 2014]. [Accessed 06 Feb. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 04 Apr. 2019] (online) Available from:
- National Health Services. Bimatoprost. [Last Reviewed: 1 June 2021]. [Accessed 09 Jun, 2023] (online) Available from:
Marketer details
Name: Allergan India Pvt Ltd
Address: No.3, Kasturba Road, Level 2, Prestige Obelisk, Bangalore – 560 001., KARNATAKA, INDIA
Country of origin: Ireland
Lab tests offered by us
Related/Popular tests
389 people bought this recentlyMRP
₹656.52
Inclusive of all taxes
3.0 ml in 1 packet
SOLD OUT